IGF2 and breast carcinoma: No association between IGF2 DMR0 methylation and breast cancer incidence was found in prediagnostic blood samples from another cohort [15], and Ito et al. therefore concluded that the observed hypomethylation of IGF2 was somatically acquired, rather than an innate epimutation.